DOI QR코드

DOI QR Code

Protective effect of resveratrol on arsenic trioxide-induced nephrotoxicity in rats

  • Zhang, Weiqian (College of Veterinary Medicine, Northeast Agricultural University) ;
  • Liu, Yan (School of Life Sciences, Inner Mongolia University for Nationalities) ;
  • Ge, Ming (College of Veterinary Medicine, Northeast Agricultural University) ;
  • Jing, Jiang (College of Veterinary Medicine, Northeast Agricultural University) ;
  • Chen, Yan (College of Veterinary Medicine, Northeast Agricultural University) ;
  • Jiang, Huijie (College of Veterinary Medicine, Northeast Agricultural University) ;
  • Yu, Hongxiang (College of Veterinary Medicine, Northeast Agricultural University) ;
  • Li, Ning (College of Veterinary Medicine, Northeast Agricultural University) ;
  • Zhang, Zhigang (College of Veterinary Medicine, Northeast Agricultural University)
  • Received : 2013.04.01
  • Accepted : 2013.09.30
  • Published : 2014.04.01

Abstract

BACKGROUND/OBJECTIVES: Arsenic, which causes human carcinogenicity, is ubiquitous in the environment. This study was designed to evaluate modulation of arsenic induced cancer by resveratrol, a phytoalexin found in vegetal dietary sources that has antioxidant and chemopreventive properties, in arsenic trioxide ($As_2O_3$)-induced Male Wistar rats. MATERIALS/METHODS: Adult rats received 3 mg/kg $As_2O_3$ (intravenous injection, iv.) on alternate days for 4 days. Resveratrol (8 mg/kg) was administered (iv.) 1 h before $As_2O_3$ treatment. The plasma and homogenization enzymes associated with oxidative stress of rat kidneys were measured, the kidneys were examined histologically and trace element contents were assessed. RESULTS: Rats treated with $As_2O_3$ had significantly higher oxidative stress and kidney arsenic accumulation; however, pretreatment with resveratrol reversed these changes. In addition, prior to treatment with resveratrol resulted in lower blood urea nitrogen, creatinine and insignificant renal tubular epithelial cell necrosis. Furthermore, the presence of resveratrol preserved the selenium content ($0.805{\pm}0.059{\mu}g/g$) of kidneys in rats treated with $As_2O_3$. However, resveratrol had no effect on zinc level in the kidney relative to $As_2O_3$-treated groups. CONCLUSIONS: Our data show that supplementation with resveratrol alleviated nephrotoxicity by improving antioxidant capacity and arsenic efflux. These findings suggest that resveratrol has the potential to protect against kidney damage in populations exposed to arsenic.

Keywords

References

  1. Yu M, Xue J, Li Y, Zhang W, Ma D, Liu L, Zhang Z. Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress. Arch Toxicol 2013;87:1025-35. https://doi.org/10.1007/s00204-013-1026-4
  2. Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci 2011; 123:305-32. https://doi.org/10.1093/toxsci/kfr184
  3. Singh S, Mulchandani A, Chen W. Highly selective and rapid arsenic removal by metabolically engineered Escherichia coli cells expressing fucus vesiculosus metallothionein. Appl Environ Microbiol 2008;74:2924-7. https://doi.org/10.1128/AEM.02871-07
  4. Wang L, Kou MC, Weng CY, Hu LW, Wang YJ, Wu MJ. Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-$\kappa$B, and MAPK pathways. Arch Toxicol 2012;86:879-96. https://doi.org/10.1007/s00204-012-0845-z
  5. Li Z, Piao F, Liu S, Wang Y, Qu S. Subchronic exposure to arsenic trioxide-induced oxidative DNA damage in kidney tissue of mice. Exp Toxicol Pathol 2010;62:543-7. https://doi.org/10.1016/j.etp.2009.07.003
  6. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493-506. https://doi.org/10.1038/nrd2060
  7. Nandi D, Patra RC, Swarup D. Effect of cysteine, methionine, ascorbic acid and thiamine on arsenic-induced oxidative stress and biochemical alterations in rats. Toxicology 2005;211:26-35. https://doi.org/10.1016/j.tox.2005.02.013
  8. Dudka J, Gieroba R, Korga A, Burdan F, Matysiak W, Jodlowska-Jedrych B, Mandziuk S, Korobowicz E, Murias M. Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity. Evid Based Complement Alternat Med 2012;2012:606183.
  9. Gulcin I. Antioxidant activity of food constituents: an overview. Arch Toxicol 2012;86:345-91. https://doi.org/10.1007/s00204-011-0774-2
  10. Csanaky I, Gregus Z. Effect of selenite on the disposition of arsenate and arsenite in rats. Toxicology 2003;186:33-50. https://doi.org/10.1016/S0300-483X(02)00604-2
  11. Kucukatay V, Turgut S, Kocamaz E, Emmungil G, Bor-Kucukatay M, Turgut G, Akca H, Bagci H. Effect of sulfite exposure on zinc, iron, and copper levels in rat liver and kidney tissues. Biol Trace Elem Res 2006;114:185-95. https://doi.org/10.1385/BTER:114:1:185
  12. Entwisle J, Hearn R. Development of an accurate procedure for the determination of arsenic in fish tissues of marine origin by inductively coupled plasma mass spectrometry. Spectrochim Acta Part B At Spectrosc 2006;61:438-43. https://doi.org/10.1016/j.sab.2006.01.008
  13. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007;224:274-83. https://doi.org/10.1016/j.taap.2006.12.025
  14. Scott E, Steward WP, Gescher AJ, Brown K. Resveratrol in human cancer chemoprevention--choosing the 'right' dose. Mol Nutr Food Res 2012;56:7-13. https://doi.org/10.1002/mnfr.201100400
  15. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007;16:1246-52. https://doi.org/10.1158/1055-9965.EPI-07-0022
  16. Zhang W, Xue J, Ge M, Yu M, Liu L, Zhang Z. Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide. Food Chem Toxicol 2013;51:87-92. https://doi.org/10.1016/j.fct.2012.09.023
  17. Lu KH, Lee HJ, Huang ML, Lai SC, Ho YL, Chang YS, Chi CW. Synergistic apoptosis-inducing antileukemic effects of arsenic trioxide and mucuna macrocarpa stem extract in human leukemic cells via a reactive oxygen species-dependent mechanism. Evid Based Complement Alternat Med 2012;2012:921430.
  18. Rodrigo R, Rivera G. Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radic Biol Med 2002;33:409-22. https://doi.org/10.1016/S0891-5849(02)00908-5
  19. Han JY, Ahn SY, Oh EH, Nam SY, Hong JT, Oh KW, Lee MK. Red ginseng extract attenuates kainate-induced excitotoxicity by antioxidative effects. Evid Based Complement Alternat Med 2012; 2012:479016.
  20. Maiti S, Chatterjee AK. Effects on levels of glutathione and some related enzymes in tissues after an acute arsenic exposure in rats and their relationship to dietary protein deficiency. Arch Toxicol 2001;75:531-7. https://doi.org/10.1007/s002040100240
  21. Kang NE, Ha AW, Kim JY, Kim WK. Resveratrol inhibits the protein expression of transcription factors related adipocyte differentiation and the activity of matrix metalloproteinase in mouse fibroblast 3T3-L1 preadipocytes. Nutr Res Pract 2012;6:499-504. https://doi.org/10.4162/nrp.2012.6.6.499
  22. Lee HS, Ha AW, Kim WK. Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo. Nutr Res Pract 2012;6:294-300. https://doi.org/10.4162/nrp.2012.6.4.294
  23. Misbahuddin M, Islam AZ, Khandker S, Ifthaker Al M, Islam N, Anjumanara. Efficacy of spirulina extract plus zinc in patients of chronic arsenic poisoning: a randomized placebo-controlled study. Clin Toxicol (Phila) 2006;44:135-41. https://doi.org/10.1080/15563650500514400
  24. Pal S, Chatterjee AK. Protective effect of N-acetylcysteine against arsenic-induced depletion in vivo of carbohydrate. Drug Chem Toxicol 2004;27:179-89.
  25. Flora SJ, Kannan GM, Kumar P. Selenium effects on gallium arsenide induced biochemical and immunotoxicological changes in rats. Chem Biol Interact 1999;122:1-13. https://doi.org/10.1016/S0009-2797(99)00112-X
  26. Anzai N, Endou H. Renal drug transporters and nephrotoxicity. In: World Congress on Alternatives and Animal Use in the Life Sciences, editor. Review Progress Made toward the 3Rs : Proceedings / 6th World Congress on Alternatives & Animal Use in the Life Sciences. Tokyo: Japanese Society for Alternatives to Animal Experiments; 2008. p.447-52.
  27. Johnson CH, Patterson AD, Idle JR, Gonzalez FJ. Xenobiotic metabolomics: major impact on the metabolome. Annu Rev Pharmacol Toxicol 2012;52:37-56. https://doi.org/10.1146/annurev-pharmtox-010611-134748

Cited by

  1. Protective effects of thymoquinone against apoptosis and oxidative stress by arsenic in rat kidney vol.38, pp.1, 2014, https://doi.org/10.3109/0886022x.2015.1103601
  2. Toxicodynamics of Lead, Cadmium, Mercury and Arsenic- induced kidney toxicity and treatment strategy: A mini review vol.5, pp.None, 2014, https://doi.org/10.1016/j.toxrep.2018.05.012
  3. Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol vol.3, pp.5, 2014, https://doi.org/10.1021/acsomega.7b01727
  4. Protective effects of Vitis vinifera (grapes) and one of its biologically active constituents, resveratrol, against natural and chemical toxicities: A comprehensive review vol.32, pp.11, 2018, https://doi.org/10.1002/ptr.6168
  5. Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology vol.11, pp.3, 2014, https://doi.org/10.3390/nu11030627
  6. The effect of aryl hydrocarbon receptor ligands on gentamicin-induced nephrotoxicity in rats vol.27, pp.14, 2014, https://doi.org/10.1007/s11356-020-08073-z